Riskpilot← Back to searchSign inGet full accessHOSPITALKOMPLEMENTARSELSKABET AROS ApS
APSActiveCVR 34893292Skejbyparken 154Other financial service activities, except insurance and pension funding n.e.c. · NACE 6499Est. 2012— employees
Revenue 2024
DKK -15K
+25% vs 2023
EBITDA margin
100.0%
-25% vs 2023
Equity ratio
92.7%
Financial strength
Net profit 2024
DKK 18K
-30% vs 2023
| Revenue | DKK -15K | +25% |
| EBITDA | DKK -15K | -25% |
| Net profit | DKK 18K | -30% |
| Total assets | DKK 260K | +7% |
| Equity | DKK 241K | +8% |
| Employees | — | — |
Legal name
HOSPITALKOMPLEMENTARSELSKABET AROS ApS
CVR number
34893292
Legal form
Anpartsselskab
NACE code
6499 · Other financial service activities, except insurance and pension funding n.e.c.
Founded
21. december 2012
Share capital
DKK 80.000
Employees
—
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af direktøren i forening med et medlem af bestyrelsen, eller af bestyrelsens formand i forening med et andet medlem af bestyrelsen, eller af den samlede bestyrelse.
Company purpose
Selskabets formål er at være komplementarselskab for Aros Privathospital af december 2012 Partnerselskab
Address
Skejbyparken 154
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | -6 | -20 | -12 | -12 | -12 | -13 | -12 | -12 | -16 | -12 | -12 | -15 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBITDA | -6 | -20 | -12 | -12 | -12 | -13 | -12 | -12 | -16 | -12 | -12 | -15 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -6 | -20 | -12 | -12 | -12 | -13 | -12 | -12 | -16 | -12 | -12 | -15 |
| Net financials | -2 | -1 | -2 | -2 | -2 | -1 | -1 | 0 | 22 | 231 | 41 | 38 |
| Profit before tax | -8 | -21 | -14 | -14 | -13 | -15 | -14 | -11 | 6 | 219 | 29 | 23 |
| Tax | -1 | -31 | -17 | -4 | 2 | 6 | 2 | -3 | 1 | 47 | 3 | 5 |
| Net profit | -7 | 10 | 3 | -10 | -15 | -20 | -15 | -8 | 5 | 172 | 25 | 18 |
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 169 | 192 | 200 | 207 | 198 | 181 | 171 | 164 | 212 | 263 | 243 | 260 |
| Equity | 77 | 87 | 90 | 80 | 65 | 45 | 30 | 22 | 26 | 198 | 223 | 241 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 93 | 106 | 111 | 127 | 133 | 136 | 141 | 142 | 185 | 65 | 19 | 19 |
| Total debt | 93 | 106 | 111 | 127 | 133 | 136 | 141 | 142 | 185 | 65 | 19 | 19 |
EBITDA margin
-1547500.0%
This company
15.8%
Market median
-9794404% vs market
20132024
Equity ratio
92.7%
This company
38.2%
Market median
+143% vs market
20132024
Return on equity
7.3%
This company
18.4%
Market median
-60% vs market
20132024
Net profit margin
1755900.0%
This company
8.1%
Market median
+21677678% vs market
20132024
Asset turnover
-0.06×
This company
1.12×
Market median
-105% vs market
20132024
Debt / equity
0.08×
This company
0.62×
Market median
+87% vs market
20132024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2012-12-21 – 2013-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
OH Management | Management | 2012 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2012 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2012 | — | — | |
| Chairman | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Board of Directors | 2021 | — | — | |
| Board of Directors | 2025 | — | — | |
| Board of Directors | 2024 | — | — | |
| Chairman | 2012 | — | — | |
| Board of Directors | 2018 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
KO HOLDING ApS | Company | 100.0% | 100.0% | 2012 |
| Individual | 10.0% | 10.0% | 2019 | |
Neurokirurgisk Klinik ApS | Company | 10.0% | 10.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Plastikkirurgisk Center Århus Speciallægecenter ApSKO HOLDING ApS
HOSPITALKOMPLEMENTARSELSKABET AROS ApS (this company)Board members of HOSPITALKOMPLEMENTARSELSKABET AROS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ole Hedeager Momsen | Management | 0 companies |
| Kaare Brixen Larsen | Board of Directors | 0 companies |
| Nidal Al-Suliman | Board of Directors | 0 companies |
| Tage Jensen | Board of Directors | 0 companies |
| Baskaran Ketharanathan | Chairman | 0 companies |
| René Drage Østgård | Board of Directors | 0 companies |
| Reinhold Helbo Jensen | Board of Directors | 0 companies |
| Anders Morten Grejs | Board of Directors | 0 companies |
| Henrik Kops Ipsen | Board of Directors | 0 companies |
| Katrin Kytønen Korsby | Chairman | 0 companies |
| Sven Fuglsig | Board of Directors | 0 companies |